HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chao-Yu Miao Selected Research

Nicotinamide Mononucleotide

5/2022Distribution of Nicotinamide Mononucleotide After Intravenous Injection in Normal and Ischemic Stroke Mice.
7/2019Targeting NAMPT as a therapeutic strategy against stroke.
1/2017Nicotinamide mononucleotide attenuates brain injury after intracerebral hemorrhage by activating Nrf2/HO-1 signaling pathway.
7/2015Regenerative Neurogenesis After Ischemic Stroke Promoted by Nicotinamide Phosphoribosyltransferase-Nicotinamide Adenine Dinucleotide Cascade.
2/2011Nicotinamide phosphoribosyltransferase protects against ischemic stroke through SIRT1-dependent adenosine monophosphate-activated kinase pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chao-Yu Miao Research Topics

Disease

10Inflammation (Inflammations)
01/2021 - 12/2011
9Hypertension (High Blood Pressure)
06/2021 - 08/2002
8Insulin Resistance
01/2021 - 09/2010
7Ischemic Stroke
05/2022 - 02/2011
7Stroke (Strokes)
06/2021 - 09/2010
7Obesity
01/2021 - 09/2010
6Body Weight (Weight, Body)
01/2021 - 01/2012
6Atherosclerosis
09/2019 - 08/2002
6Brain Ischemia (Cerebral Ischemia)
01/2016 - 02/2011
5Brain Infarction
05/2022 - 02/2011
4Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
05/2022 - 01/2012
4Hypertrophy
06/2021 - 08/2002
3Brain Injuries (Brain Injury)
10/2020 - 01/2017
3Ischemia
01/2016 - 02/2011
3Necrosis
09/2014 - 01/2012
3Cardiovascular Diseases (Cardiovascular Disease)
12/2011 - 08/2002
2Non-alcoholic Fatty Liver Disease
01/2021 - 01/2016
2Fatty Liver
01/2021 - 01/2016
2Neoplasms (Cancer)
02/2018 - 05/2011
2Neuroinflammatory Diseases
11/2017 - 01/2017
2Pathologic Processes
05/2016 - 12/2011
2Fibrosis (Cirrhosis)
01/2016 - 08/2002
2Cerebral Infarction
01/2016 - 10/2011
2Myocardial Infarction
08/2013 - 08/2003
2Vascular Diseases (Vascular Disease)
02/2012 - 01/2012
2Cardiac Arrhythmias (Arrythmia)
04/2004 - 08/2003
1Liver Cirrhosis (Hepatic Cirrhosis)
01/2021
1Colitis
06/2020
1Traumatic Brain Injuries (Traumatic Brain Injury)
01/2020
1Atherosclerotic Plaque (Atheroma)
09/2019
1Metaplasia
01/2019
1Cerebral Hemorrhage
01/2017
1Hematoma
01/2017
1Brain Edema (Cerebral Edema)
01/2017
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
06/2016

Drug/Important Bio-Agent (IBA)

11Nicotinamide PhosphoribosyltransferaseIBA
09/2019 - 09/2010
9NAD (NADH)IBA
05/2022 - 05/2011
8Glucose (Dextrose)FDA LinkGeneric
01/2021 - 08/2003
5Nicotinamide MononucleotideIBA
05/2022 - 02/2011
5Insulin (Novolin)FDA Link
12/2015 - 08/2003
4Proteins (Proteins, Gene)FDA Link
05/2016 - 01/2012
4AdipokinesIBA
04/2014 - 09/2010
3Therapeutic UsesIBA
05/2022 - 01/2017
3salicylhydroxamic acid (SHAM)IBA
06/2021 - 11/2005
3CholesterolIBA
09/2019 - 11/2005
3Beclin-1IBA
01/2019 - 01/2012
3EnzymesIBA
07/2015 - 08/2002
2Biological ProductsIBA
05/2022 - 11/2012
2P7C3-A20IBA
01/2021 - 01/2016
2LipidsIBA
01/2021 - 01/2016
2carbazoleIBA
01/2021 - 01/2016
2Triglycerides (Triacylglycerol)IBA
09/2019 - 05/2012
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2019 - 11/2011
2nicotinamide-beta-ribosideIBA
07/2019 - 01/2016
2Neuroprotective AgentsIBA
07/2019 - 01/2016
2Blood Glucose (Blood Sugar)IBA
11/2016 - 01/2012
2LeptinIBA
12/2015 - 05/2012
2Oxygen (Dioxygen)IBA
09/2014 - 01/2012
2LipopolysaccharidesIBA
02/2013 - 11/2011
2Adenosine Monophosphate (AMP)IBA
01/2012 - 02/2011
2KetanserinIBA
11/2011 - 07/2003
1MT-1207IBA
06/2021
1allisartan isoproxilIBA
06/2021
1AldosteroneIBA
06/2021
1AngiotensinsIBA
06/2021
1Malondialdehyde (Propanedial)IBA
06/2021
1NADPH Oxidases (NAD(P)H oxidase)IBA
06/2021
1Caspase 3 (Caspase-3)IBA
01/2021
1AMP-Activated Protein KinasesIBA
01/2021
1fibroblast growth factor 21IBA
01/2021
1Fibroblast Growth Factor 1 (FGF-1)IBA
01/2021
1Protein Kinases (Protein Kinase)IBA
01/2021
1CytokinesIBA
12/2020
1Neurotransmitter Agents (Neurotransmitter)IBA
10/2020
1sodium sulfate (sodium bisulfate)FDA LinkGeneric
06/2020
1Drinking WaterIBA
06/2020
1Dextrans (Dextran)FDA Link
06/2020
170-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA
06/2020
1Pharmaceutical PreparationsIBA
01/2020
1ChemokinesIBA
09/2019
1Fatty Acids (Saturated Fatty Acids)IBA
09/2019
1Apolipoproteins E (ApoE)IBA
09/2019
1HDL CholesterolIBA
09/2019
1LDL CholesterolIBA
09/2019
1Niacinamide (Nicotinamide)FDA LinkGeneric
07/2019
1Tight Junction ProteinsIBA
11/2017
1Peroxidase (Myeloperoxidase)IBA
11/2017
1Matrix Metalloproteinases (MMPs)IBA
11/2017
1Collagenases (Collagenase)FDA Link
01/2017
1Hemoglobins (Hemoglobin)IBA
01/2017
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
01/2017
1Antimicrobial PeptidesIBA
11/2016
1LactoferrinIBA
11/2016
1Mucin-2IBA
11/2016

Therapy/Procedure

8Therapeutics
01/2021 - 11/2007
3Denervation
12/2003 - 08/2002
2Intravenous Injections
05/2022 - 12/2015
2Transplantation
10/2020 - 01/2020
2Oral Administration
01/2016 - 03/2005
1Surgical Instruments (Clip)
06/2021